Actover Pharmaceutical Group Participates in the 10th IRAN PHARMA Exhibition
Actover Pharmaceutical Group, with active participation in the 10th edition of the Pharmaceutical and Related Industries Exhibition (IRAN PHARMA), hosted chief executives of several pharmaceutical companies, manufacturers and industrial players in the pharmaceutical supply chain, trade delegations, colleagues, student groups, and various domestic and international visitors. The three-day exhibition provided a valuable opportunity to expand exchanges and foster joint cooperation in scientific, manufacturing, and export fields.
Actoverco Medical Director Stated: A Strong Commitment to the “Pharmacovigilance” System Ensures the Safety and Reliability of Actover Products
The first National Conference on “Health Product Vigilance” was held on the occasion of World Patient Safety Day by the Deputy for Food and Drug of Iran University of Medical Sciences and the Food and Drug Administration, with the support of Actover Pharmaceutical Group.
Actover Group Unveils “Zeponim” for the Management of Multiple Sclerosis and Ulcerative Colitis
Here’s the English translation of that sentence:
**The oral capsule *Zeponim* (Ozanimod), developed by specialists at Alborz Zagros Pharmaceutical Company — a subsidiary of Actover Group — has been produced for the management of relapsing Multiple Sclerosis (MS) and Ulcerative Colitis (an inflammatory bowel disease).**
Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025
Tehran, July 2025 – At the sidelines of the 13th Iran Supplex,Iran’s leading exhibition and congress for dietary, nutritional, and sports supplements.
Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology
Tehran, May 2025 — Actover Pharmaceutical Group participated in the 32nd Iranian Congress of Neurology and Clinical Electrophysiology, presenting a wide range of its neurological products to healthcare professionals and field experts.
Labor Day Tribute from Actoverco
International Labor Day is a global tribute to the unwavering will and tireless hands that shape the future. It is a meaningful occasion to honor those whose dedication, expertise, and commitment drive the engines of progress and prosperity.
Eid al-Fitr: A Celebration of Faith, Renewal, and Prosperity
Eid al-Fitr, a celebration of devotion and righteousness, marks the dawn of divine mercy and the season of harvesting the vibrant fruits of answered prayers. Wishing all Muslims around the world a blessed Eid.
First AcTrip Conference Held to Address Hypothyroidism Screening, Diagnosis, and Treatment
The first session of the AcTrip (Actoverco Thyroid Insight Practice) conference series, organized by Actoverco Pharmaceutical Group, was held with the aim of reviewing the challenges of screening, diagnosis, treatment, and follow-up of hypothyroidism (underactive thyroid). The event brought together 300 distinguished physicians and leading endocrinologists.
Atipharmed Supports the 6th International Congress on Minimally Invasive Techniques in Gynecology and Endometriosis
The 6th International Congress on Minimally Invasive Techniques in Gynecology, Obstetrics, and Endometriosis took place from January 23 to 25 at Abureihan Hall, Shahid Beheshti University, with Atipharmed, a subsidiary of Actoverco, as its key sponsor.
Scientific Conference on the Effects of Hormone Replacement Therapy (HRT) in Menopause
The scientific seminar on the effects of hormone replacement therapy (HRT) during menopause, introducing Gynati and Prequin drugs by Ati Pharmed Pharmaceutical Company, was held.
Holding the 21st MS Congress of Iran with the participation of Actoverco
The 21st MS Congress of Iran was held from December 4th to 6th, 2024, and organized by the Multiple Sclerosis Research Center of Tehran University of Medical Sciences at the International Conference Hall of the Olympic Hotel.
Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress
The 24th Congress of Gastrointestinal and Liver Diseases was held with the support of Actover Pharmaceutical Group.